🧠 COVID-19 Vaccines and the Media-Government Complex: A Critical Look at Influence, Oversight, and Accountability

Five years after the launch of the global COVID-19 vaccination campaign, questions persist about the role of news organizations, federal health agencies, and the Biden administration in shaping public perception…[...]

Read More

🫁 Long COVID and Shortness of Breath: Causes, Vaccine-Linked Harms, and Emerging Treatments (2025 Overview)

Five years into the pandemic, shortness of breath remains one of the most persistent and debilitating symptoms of Long COVID, affecting millions globally. This article synthesizes findings from 2025 peer-reviewed…[...]

Read More

📊 Documented Increases in Specific Conditions from COVID Vaccination

ConditionObserved IncreaseVaccine TypeMyocarditis (heart inflammation)Up to 2.6× higher after 4th mRNA dosePfizer, ModernaPericarditis (heart lining)~1.7× higher after 1st dosemRNA vaccinesGuillain-Barré Syndrome190 cases observed vs. 66 expectedAstraZenecaCerebral venous sinus thrombosis3.2× higher…[...]

Read More

Moderna’s COVID-19 Vaccine Spikevax Receives Full FDA Approval for Children Aged 6 Months to 11 Years at “Increased Risk”

by Jim Hᴏft, TGP The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old…[...]

Read More

Post-inflammatory Pigmentary Alteration (PIPA)-Like Disorder Following COVID-19 Vaccination

Larry M. Bush • Priscila M. Fiallo • Maria T. Vazquez-Pertejo, DOI: 10.7759/cureus.87222  Abstract SARS-CoV-2 (COVID-19) infection has been associated with various cutaneous manifestations presenting concomitantly with and following clinical resolution of active infection. Similarly,…[...]

Read More